Search results
What Makes Immuneering Corporation (IMRX) a New Buy Stock
Zacks via Yahoo Finance· 2 years agoImmuneering Corporation (IMRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing...
Immuneering Corporation (IMRX) Soars 16.9%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 1 year agoImmuneering Corporation (IMRX) was a big mover last session on higher-than-average trading volume....
Wall Street Analysts Believe Immuneering Corporation (IMRX) Could Rally 102.51%: Here's is How to...
Zacks via Yahoo Finance· 1 year agoThe average of price targets set by Wall Street analysts indicates a potential upside of 102.5% in...
With 37% ownership, Immuneering Corporation (NASDAQ:IMRX) has piqued the interest of institutional...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Given the large stake in the stock by institutions, Immuneering's stock price might be...
Immuneering (NASDAQ:IMRX) shareholders have endured a 77% loss from investing in the stock a year...
Simply Wall St. via Yahoo Finance· 2 years agoIt is a pleasure to report that the Immuneering Corporation (NASDAQ:IMRX) is up 49% in the last...
Immuneering Corporation (NASDAQ:IMRX) insiders have significant skin in the game with 28% ownership
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Immuneering's significant insider ownership suggests inherent interests in company's...
Immuneering Corporation (IMRX) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoImmuneering Corporation (IMRX) delivered earnings and revenue surprises of 15.38% and 65.19%,...
Immuneering (IMRX) Plummets 71% in One Week: Here's Why
Zacks via Yahoo Finance· 2 months agoImmuneering (IMRX) plunges after multiple Wall Street analysts downgraded the stock on lackluster...
We Think Immuneering (NASDAQ:IMRX) Needs To Drive Business Growth Carefully
Simply Wall St. via Yahoo Finance· 3 weeks agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Immuneering Director Acquires 7.5% More Stock
Simply Wall St. via Yahoo Finance· 2 months agoPotential Immuneering Corporation (NASDAQ:IMRX) shareholders may wish to note that the Director, Peter Feinberg, recently bought US$183k worth of stock,...
